Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q1 2016 · 10-Q
Revenue$160.00K$160.00K−80.5% vs Q1 2015 Net Income-$1.81M-$1.81MN/M vs Q1 2015 EPS Diluted-$0.02-$0.02N/M vs Q1 2015 Operating Income-$1,813,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,147,000N/M Margins · derivedOperating margin-1133.1%−960.2 pt vs Q1 2015
Net margin-1128.1%−956.0 pt vs Q1 2015
ended Sep 30, 2015 · filed Nov 13, 2015 · 44 d after period end